Long-term Cost-effectiveness of Two GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus in the Italian Setting: Liraglutide Versus Lixisenatide

Autor: Hunt, Barnaby, Kragh, Nana, McConnachie, Ceilidh C., Valentine, William J., Rossi, Maria C., Montagnoli, Roberta
Zdroj: In Clinical Therapeutics July 2017 39(7):1347-1359
Databáze: ScienceDirect